Duyuru • May 16
Amesite Inc. announced delayed 10-Q filing On 05/15/2026, Amesite Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. New Risk • May 05
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 32% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (32% increase in shares outstanding). Revenue is less than US$1m (US$289k revenue). Market cap is less than US$10m (US$5.27m market cap). Duyuru • Apr 28
Amesite Inc. has filed a Follow-on Equity Offering in the amount of $1.000003 million. Amesite Inc. has filed a Follow-on Equity Offering in the amount of $1.000003 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 696,866
Price\Range: $1.435
Discount Per Security: $0.1
Transaction Features: Registered Direct Offering Duyuru • Apr 24
Amesite Inc. has withdrawn its Follow-on Equity Offering in the amount of $5 million. Amesite Inc. has withdrawn its Follow-on Equity Offering in the amount of $5 million.
Security Name: Common Stock
Security Type: Common Stock
Price\Range: $1.8
Discount Per Security: $0.126
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Price\Range: $1.799
Discount Per Security: $0.12593 New Risk • Apr 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (US$289k revenue). Market cap is less than US$10m (US$8.05m market cap). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change). Duyuru • Apr 21
Amesite Inc. has filed a Follow-on Equity Offering in the amount of $5 million. Amesite Inc. has filed a Follow-on Equity Offering in the amount of $5 million.
Security Name: Common Stock
Security Type: Common Stock
Price\Range: $1.8
Discount Per Security: $0.126
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Price\Range: $1.799
Discount Per Security: $0.12593 New Risk • Mar 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$2.5m free cash flow). Revenue is less than US$1m (US$289k revenue). Market cap is less than US$10m (US$8.23m market cap). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Reported Earnings • Feb 06
Second quarter 2026 earnings released: US$0.16 loss per share (vs US$0.40 loss in 2Q 2025) Second quarter 2026 results: US$0.16 loss per share (improved from US$0.40 loss in 2Q 2025). Revenue: US$108.1k (up US$95.3k from 2Q 2025). Net loss: US$732.5k (loss narrowed 35% from 2Q 2025). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. New Risk • Dec 24
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.79m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$2.7m free cash flow). Shareholders have been substantially diluted in the past year (64% increase in shares outstanding). Revenue is less than US$1m (US$194k revenue). Market cap is less than US$10m (US$9.79m market cap). Duyuru • Dec 19
Amesite Inc. Accelerates Growth with Launch of AI-Native NurseMagic EMR Amesite Inc. announced the launch of the NurseMagic EMR, marking a significant expansion of the Company's platform following a year of strong sequential revenue growth and enterprise traction. The AI-native, modular EMR extends NurseMagic from a point-of-care solution into core post-acute care infrastructure, supporting both coexistence with legacy systems and full system replacement. Amesite expects to begin onboarding EMR customers in January 2026. Amesite's revenue growth has occurred in clear step changes aligned with the rollout of progressively higher-value product tiers, progressing from Individual to Teams, Teams+, and Enterprise offerings. Following the May 2025 launch of Teams+, the Company reported a 2.4x increase in quarterly revenue. With the July 2025 introduction of its Enterprise tier, priced on patient census rather than individual users, revenues increased 82% in the fourth quarter. continued expansion of Enterprise capabilities and industry outreach drove an additional 69% quarter-over-quarter revenue increase in the first quarter of fiscal 2026. McKinsey estimates that generative AI could create $2.6 trillion to $4.4 trillion in annual economic value, primarily when AI is embedded into core operating systems rather than used as standalone tools.1 In under 18 months since its June 2024 public launch, NurseMagic has progressed from an AI assistant for individual clinicians to an enterprise platform with census-based pricing and now an AI-native EMR. The U.S. post-acute care market is one of healthcare's largest and fastest-growing segments, valued at more than $470 billion in 2024 and projected to exceed $850 billion in the coming years. Reported Earnings • Oct 26
First quarter 2026 earnings released: US$0.14 loss per share (vs US$0.34 loss in 1Q 2025) First quarter 2026 results: US$0.14 loss per share (improved from US$0.34 loss in 1Q 2025). Net loss: US$642.3k (loss narrowed 29% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Sep 30
Full year 2025 earnings released: US$1.03 loss per share (vs US$1.73 loss in FY 2024) Full year 2025 results: US$1.03 loss per share (improved from US$1.73 loss in FY 2024). Net loss: US$3.62m (loss narrowed 18% from FY 2024). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Duyuru • Jul 14
Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable Market Amesite Inc. announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Developed in direct response to customer demand, NurseMagic™ Enterprise integrates advanced, AI-powered capabilities into existing workflows — seamlessly and compliantly. By aligning pricing with patient census, Amesite believes this offering significantly increases its addressable market and supports long-term revenue growth. NurseMagic™ Enterprise includes:Seamless EMR integration. NurseMagic™ Enterprise enables bi-directional data transfer and connectivity with electronic medical records (EMRs), allowing documentation created in NurseMagic™ Enterprise to populate directly into clinical systems. This integration is designed to fit seamlessly into existing workflows — preserving continuity for staff while delivering unparalleled documentation efficiency. Automated interdisciplinary team (IDT) reporting. NurseMagic™ now generates formatted IDT reports automatically, streamlining one of the most time-intensive compliance processes for home health and hospice agencies. This feature is built to operate within current team structures — saving time without requiring teams to change how they work. Custom-formatted documentation for compliance and billing. NurseMagic™ Enterprise supports customer-specific templates for documentation required by payers, regulators, and internal teams. This assures that providers can continue to use their own established forms — now generated faster and with greater consistency with NurseMagic™’s powerful, proprietary AI tools. Census-based pricing that scales with care delivery. By tying pricing to patient census rather than staff count, NurseMagic™ enables organizations to deploy across full care teams with clarity and control. This model supports growth without operational disruption — and positions Amesite to capture revenue as census expands. With the launch of NurseMagic™ Enterprise, Amesite will discontinue new sales of its entry-level B2B Teams plan. Going forward, B2B customers will choose between Teams Plus+, intended for organizations with smaller patient censuses, and the new NurseMagic™ Enterprise Tier, which supports larger-scale deployment and full-agency efficiency. Existing Teams customers will continue to be supported. Amesite believes that consolidating around these two enhanced tiers enables the Company to capture more value from each organization served and positions it to drive stronger recurring revenue growth. New Risk • Jul 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.1m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Shareholders have been substantially diluted in the past year (80% increase in shares outstanding). Revenue is less than US$1m (US$83k revenue). Minor Risk Market cap is less than US$100m (US$12.7m market cap). Duyuru • Jun 26
Amesite Inc.'s HIPAA Compliant NurseMagic App Now Operates in 16 Languages - Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses Amesite Inc. announced that its app, NurseMagic, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) -- accounting for 19.2% of the nursing workforce -- and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL); International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone; Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO. Reported Earnings • May 17
Third quarter 2025 earnings released: US$0.16 loss per share (vs US$0.56 loss in 3Q 2024) Third quarter 2025 results: US$0.16 loss per share (improved from US$0.56 loss in 3Q 2024). Net loss: US$663.4k (loss narrowed 54% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Duyuru • May 06
Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand Amesite Inc. announced the successful launch of a higher-priced enterprise tier of service of its app, NurseMagicTM. Amesite reports that businesses demanded more capacity after incorporating NurseMagicTM fully into their workflows - and have reported a strong willingness-to-pay for the increased usage at a higher price point. Amesite also reports that customers also wanted access to advanced analytics, now accessible 24/7 with the Teams Plus+ tier of service. Amesite reports a marked increase in enterprise clients deploying NurseMagic™ across entire clinical and non-clinical teams, from nurses and CNAs to chaplains, aides, and coordinators. As these customers scale usage, they gain access to real-time insights, productivity metrics, and tools that reduce costs and improve retention with the new pricing tier. This new tier follows announcements regarding meeting HIPAA regulation, delivering to the growing hospice segment and delivery of solutions for non-clinical workers in addition to clinical staff. Duyuru • Apr 23
Amesite Announces NurseMagic Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises Amesite Inc. announced NurseMagic now meets HIPAA requirements for all users. This extension ensures that all usage—individual or enterprise—meets regulatory standards for handling sensitive healthcare information. Amesite announced that it met HIPAA requirements for enterprises late last year, and subsequently reported increased sales in B2B. To meet HIPAA requirements, care providers are required to execute a Business Associate Agreement (BAA) with their software vendors. NurseMagic now provides a BAA for all users, whether licenses are purchased by enterprises or by individuals. Any provider can confidently enter patient details or other personally identifiable health information (PHI) into NurseMagic™’s safe, secure environment. Users can copy and paste documentation produced with NurseMagic into any electronic medical record (EMR) system, enabling them to take advantage of NurseMagic™’s AI capabilities, no matter their current software infrastructure. Duyuru • Mar 11
Amesite Announces Successful Soft Rollout of NurseMagic Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50% Amesite Inc. announced the early adoption of its non-clinical caregiver tool in NurseMagic. The Caregiver NurseMagic Solution directly supports non-clinical workers in their day-to-day jobs, reducing the need for intensive intervention by management, and improving documentation, communication and patient care. Amesite sales are focused on home health care and skilled nursing. Agencies and corporations in these segments employ both clinical and non-clinical staff. Broadly, there are almost 3 million home health care and skilled nursing staff in the U.S., of which over 1.5 million are non-clinical healthcare support workers. By expanding NurseMagic solutions to meet the needs of non-clinical workers, Amesite estimates that it has expanded its addressable market for enterprise sales alone by around 50%. Amesite reports that an increasing number of customers have adopted NurseMagic for their entire teams, which include non-clinical staff such as CNAs, chaplains, social workers and nurse aides. Over the last three months, Amesite reported that its contracts with hospice providers have grown by over 3,000%, and contract sizes have increased by nearly 1,000%. This comes on the heels of Amesite's recent rollout of its automated purchase process that enables contract expansion with a few clicks, substantially shortening its sales cycle as it reaches the over 50,000 businesses in its target segments. New Risk • Feb 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Revenue is less than US$1m (US$86k revenue). Minor Risk Market cap is less than US$100m (US$11.6m market cap). New Risk • Feb 12
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 57% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Revenue is less than US$1m (US$86k revenue). Minor Risks Share price has been volatile over the past 3 months (18% average weekly change). Market cap is less than US$100m (US$13.4m market cap). Reported Earnings • Feb 09
Second quarter 2025 earnings released: US$0.40 loss per share (vs US$0.36 loss in 2Q 2024) Second quarter 2025 results: US$0.40 loss per share (further deteriorated from US$0.36 loss in 2Q 2024). Net loss: US$1.12m (loss widened 24% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Jan 10
Chairperson recently bought US$1m worth of stock On the 7th of January, Ann Sastry bought around 333k shares on-market at roughly US$3.00 per share. This transaction amounted to 61% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Ann's only on-market trade for the last 12 months. Duyuru • Jan 09
Amesite Inc. has completed a Follow-on Equity Offering in the amount of $4.865001 million. Amesite Inc. has completed a Follow-on Equity Offering in the amount of $4.865001 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 1,201,667
Price\Range: $3
Discount Per Security: $0.24
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 420,000
Price\Range: $3
Discount Per Security: $0.12 Duyuru • Jan 07
Amesite Inc. has filed a Follow-on Equity Offering. Amesite Inc. has filed a Follow-on Equity Offering.
Security Name: Common Stock
Security Type: Common Stock
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant Duyuru • Dec 04
Amesite Receives a Deficiency Letter from the Listing Qualifications Department of the Nasdaq Stock Market On November 26, 2024, Amesite Inc. received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market, nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years. Pursuant to the Nasdaq Letter, the Company has 45 calendar days from the date of the Nasdaq Letter to submit a plan to regain compliance and the Company intends to submit such a plan during this period. If it accepts the plan, Nasdaq can grant an extension of up to 180 calendar days from the date of the Nasdaq Letter to evidence compliance. In the event the plan is not accepted by Nasdaq, or in the event the plan is accepted and the 180-day extension period granted but the Company fails to regain compliance within such plan period, the Company would have the right to a hearing before an independent panel. The hearing request would stay any suspension or delisting action pending the conclusion of the hearing process and the expiration of any additional extension period granted by the panel following the hearing. The Company intends to take all reasonable measures available to regain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq. However, there can be no assurance that Nasdaq will grant the Company’s request for an extension or that the Company will ultimately regain compliance with all applicable requirements for continued listing. Neither the Nasdaq Letter nor the Company’s noncompliance have an immediate effect on the listing or trading of the Company’s common shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AMST”. Duyuru • Nov 28
Amesite Inc., Annual General Meeting, Jan 21, 2025 Amesite Inc., Annual General Meeting, Jan 21, 2025. New Risk • Nov 20
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 9.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.1m free cash flow). Revenue is less than US$1m (US$115k revenue). Market cap is less than US$10m (US$6.62m market cap). Minor Risk Shareholders have been diluted in the past year (9.8% increase in shares outstanding). Reported Earnings • Nov 17
First quarter 2025 earnings released: US$0.34 loss per share (vs US$0.35 loss in 1Q 2024) First quarter 2025 results: US$0.34 loss per share. Net loss: US$908.0k (loss widened 1.9% from 1Q 2024). Reported Earnings • Oct 01
Full year 2024 earnings released: US$1.73 loss per share (vs US$1.68 loss in FY 2023) Full year 2024 results: US$1.73 loss per share (further deteriorated from US$1.68 loss in FY 2023). Net loss: US$4.40m (loss widened 6.0% from FY 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings. Duyuru • Jul 16
Amesite Inc. Launches PREACTO App in Beta to Power Safety and Security At Home, Work, School and in Public Venues Amesite Inc. announced that the beta registration is now available for PREACTO, an innovative and proprietary app designed for personal safety and security. The new web app uses AI to provide helpful and easy-to-use tools for people who want to make their safety and security a priority, allowing them to proactively assess threats, plan safe routes and activities, update law enforcement, notify their circle of family and friends, and more. The app will also offer Active Shooter Preparedness content developed together with world renowned expert Chris Grollnek, #ActiveShooterexpert, and founder of the Active Shooter Prevention Project. Amesite and ASPP announced their collaboration in March to create the app. The app targets serving Grollnek’s expansive audience and customer base, including Fortune 100 and 500 companies, small to large corporations and businesses, the entire government sector, public entities, and other organizations. This broad client base reflects the universal need for effective crisis response training across all sectors of society. Americans are increasingly focused on reducing crime, with 58% of U.S. adults stating that crime reduction should be a top priority of the President and Congress, up from 47% in 2021. 40% of Americans, the highest percentage in three decades, report that they would be afraid to walk alone at night within a mile of their home. Fully 66% of adults reported that they avoided common activities because of fear of crime, including attending public events, visiting central areas of cities, taking walks, exercising or visiting local parks. PREACTO’s toolkit is designed to make these activities safer and more secure. RescueCall instantly notifies loved ones and emergency services, ensuring swift assistance. CrimeMap provides real-time updates on local crime activities, helping users avoid dangerous areas. The app’s SafeZone feature offers risk assessments based on a user’s current location, while SafePath provides the safest route to any destination. Additionally, WeaponSight uses phone cameras to identify potential threats, and IncidentReporter enables fast documentation and reporting of threatening behavior to law enforcement or workplace authorities. Duyuru • Jul 12
Amesite Inc. Announces AI-Powered Document Storage and Study Tools on NurseMagic™? App to Power Instantaneous Training for Nurses and Nursing Students Amesite Inc. announced that its NurseMagicTM app now supports nursing students and professionals ranging from CNAs and LPNs to APRN-CNPs and NPs. The functionality supports any type of documentation, training and learning. NurseMagicTM has experienced rapid adoption by nurses following its release to the general public, targeting over 5.2 million nurses. Its proprietary technology has demonstrated 93% accuracy when tested on prep questions for the NCLEX, the exam that must be passed by nurses in the U.S. and Canada in order to be licensed. Users can upload pdf, video and audio files to instantly create transcripts, summaries and even quizzes and flashcards based on the material. Uploadable content spans recorded and written lecture materials, training materials and professional guidelines along with informal materials created via mentorship. With the new functionality, nurses can access instantaneous training. Additionally, users can share materials easily on the app and create their own file structures, enabling scaling of distribution of informal and formal learning, training and other professional materials. Reported Earnings • May 13
Third quarter 2024 earnings released: US$0.56 loss per share (vs US$0.37 loss in 3Q 2023) Third quarter 2024 results: US$0.56 loss per share (further deteriorated from US$0.37 loss in 3Q 2023). Net loss: US$1.43m (loss widened 54% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings. Duyuru • Apr 24
Amesite Inc. Launches Revolutionary NurseMagic App in Beta to Empower 5.2 Million Nurses with AI Tools Amesite Inc. announced the beta release of NurseMagic™, an innovative and proprietary app designed for nurses. This new web app uses AI to provide helpful and easy-to-use tools for over 5.2 million nurses, making their daily tasks easier and more efficient. Additionally, with its status as a Joint Provider with PACE, also offers convenient, accredited continuing education (CE) programs to nurses on the app, enabling them to meet requirements for licensure. NurseMagic™ features include: MedDecode: Quickly translates medical terms into simple language. Professional Email Generator: Creates practical work emails quickly. CareTalk: Assists nurses in talking to patients effectively and with compassion. Wellness Break: Coaches nurses on taking effective breaks during the day. MedExplainer: Enables nurses to explain medical practices to patients. Image-to-Text: Converts images to text for easy reading and communication.MedUverse: Offers key information about medications. NurseTea: Collects instant feedback through surveys that are shared with the community. Reported Earnings • Feb 16
Second quarter 2024 earnings released: US$0.36 loss per share (vs US$0.28 loss in 2Q 2023) Second quarter 2024 results: US$0.36 loss per share (further deteriorated from US$0.28 loss in 2Q 2023). Revenue: US$41.4k (down 83% from 2Q 2023). Net loss: US$905.6k (loss widened 30% from 2Q 2023). Duyuru • Jan 24
Amesite Inc. Launches Active Shooter Preparedness Training with Expert Chris Grollnek Amesite Inc. announced the launch of its Active Shooter Preparedness Training program. This essential training is developed in collaboration with renowned active shooter prevention expert Chris Grollnek, M.S., Founder and Managing Principal of the Active Shooter Prevention Project, LLC (ASPP). Amesite's partnerships with regional and community colleges aim to deploy these learnings to a wider audience and enhance safety protocols across the country. Duyuru • Jan 05
Amesite Inc. Partners with Central Michigan University to Launch A Pioneering Asynchronous Implicit Bias Course for Healthcare Professionals Amesite Inc. announced the launch of a new asynchronous Implicit Bias course tailored for healthcare professionals. This course is the result of a partnership between Amesite and CMU's College of Medicine, along with key insights from Dr. Sheri Pickover, a distinguished professor and program director in CMU's Counseling, Educational Leadership & Higher Education department. Delivered through CMU's Online Professional Education portal powered by Amesite's cutting-edge learning platform, this course is meticulously designed to deepen the understanding of implicit bias in healthcare settings. It goes beyond raising awareness, enabling participants to apply these vital insights in reforming healthcare policies and practices. Key Course Highlights: LARA Requirements: The asynchronous course meets the LARA two-hour training requirement as established by the State of Michigan. Medical Professionals: Earn 2.0 American Medical Association's Physician's Recognition Award Category one credits upon successful completion. Educators: Fulfill 1.0 Student Continuing Education Clock Hour (SCECH) requirements mandated by the Michigan Department of Education (MDE). This course will help foster inclusivity and reduce implicit bias within healthcare. The asynchronous course equips healthcare professionals, educators and advocates with the knowledge and tools necessary to make a tangible difference in their respective fields. Board Change • Dec 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. Director George Parmer was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Dec 09
Amesite Inc., Annual General Meeting, Jan 18, 2024 Amesite Inc., Annual General Meeting, Jan 18, 2024, at 08:45 US Eastern Standard Time. Agenda: To consider the election of three Class III Directors to hold office until successors are duly elected and qualified or until the 2026 Annual Meeting of Stockholders; to consider the ratification of the appointment of Turner, Stone & Company, L.L.P. as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024; and to transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof. Duyuru • Sep 28
Amesite Inc. announced delayed annual 10-K filing On 09/27/2023, Amesite Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Duyuru • Jun 29
Amesite Announces V6.3, with Streamlined, AI-First Infrastructure to Enable Customization and Scale for Its Enterprise Customers Amesite Inc. announces that V6.3 will be available to its Customers on July 10, 2023. By implementing Azure's cloud solutions, Amesite has enhanced its platform’s efficiency and ensured secure authentication with Azure AD B2C. The incorporation of Azure's latest database technology enables Amesite to deliver services faster and improve user experiences. The centralization of Amesite’s innovation deployments allows rapid access to new features such as games and other AI offerings. This significant update reaffirms Amesite’s dedication to addressing customers' ever-evolving needs and delivering an unrivaled user experience. Amesite’s V6.3 includes upgraded cybersecurity with centralized security measures and updates to fortify protection against cyber threats. Enhanced visibility achieved through centralized monitoring allows proactive identification of vulnerabilities, paired with the ability to rapidly deploy security patches across all tenants. In addition, Amesite’s scalable customer support facilitates frictionless resource allocation to manage Customer inquiries and onboarding efficiently. New Risk • Jun 08
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.35m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Earnings have declined by 21% per year over the past 5 years. Revenue is less than US$1m (US$880k revenue). Market cap is less than US$10m (US$9.35m market cap). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Reported Earnings • May 18
Third quarter 2023 earnings released: US$0.37 loss per share (vs US$1.12 loss in 3Q 2022) Third quarter 2023 results: US$0.37 loss per share (improved from US$1.12 loss in 3Q 2022). Revenue: US$204.6k (down 2.4% from 3Q 2022). Net loss: US$928.0k (loss narrowed 58% from 3Q 2022). Board Change • May 14
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. Director George Parmer was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 16
First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022) First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 8.3% growth forecast for the Consumer Services industry in the US. Reported Earnings • Nov 12
First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022) First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Consumer Services industry in the US. Reported Earnings • Sep 29
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: US$0.39 loss per share (improved from US$0.59 loss in FY 2021). Revenue: US$697.0k (up 3.3% from FY 2021). Net loss: US$9.06m (loss narrowed 22% from FY 2021). Revenue missed analyst estimates by 64%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 85% p.a. on average during the next 2 years, compared to a 7.9% growth forecast for the Consumer Services industry in the US. Reported Earnings • May 14
Third quarter 2022 earnings released: US$0.093 loss per share (vs US$0.11 loss in 3Q 2021) Third quarter 2022 results: US$0.093 loss per share (up from US$0.11 loss in 3Q 2021). Net loss: US$2.22m (loss narrowed 4.6% from 3Q 2021). Recent Insider Transactions • Nov 20
Chairperson recently bought US$50k worth of stock On the 19th of November, Ann Sastry bought around 38k shares on-market at roughly US$1.31 per share. This was the largest purchase by an insider in the last 3 months. Ann has been a buyer over the last 12 months, purchasing a net total of US$106k worth in shares. Reported Earnings • Nov 18
First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.31 loss in 1Q 2021) First quarter 2022 results: Net loss: US$2.38m (loss narrowed 53% from 1Q 2021). Reported Earnings • Sep 11
Full year 2021 earnings released: US$0.59 loss per share Full year 2021 results: Net loss: US$11.6m (loss widened 178% from FY 2020). Recent Insider Transactions • Jun 12
Founder recently bought US$56k worth of stock On the 11th of June, Ann Sastry bought around 15k shares on-market at roughly US$3.73 per share. This was the largest purchase by an insider in the last 3 months. This was Ann's only on-market trade for the last 12 months. Duyuru • Jun 03
Amesite Inc. Launches Remote Upskilling Courses on Microsoft Azure, in Partnership with Wayne State University Amesite Inc. announced its launch of services on Microsoft Azure. Running on Azure and in partnership with universities, Amesite is well-positioned to drive digital transformation and upskill professionals across markets. According to Knowledge Sourcing Intelligence, the global online education market is projected to reach $319 billion by 2025, a CAGR of 9.23% from 2020 to 2025. The workplace is changing faster than ever. In partnership with Amesite, universities can launch the necessary learning programs to keep learners upskilled, quickly and effectively. With Amesite on Azure, these learning programs can drive digitalization and impact markets at an exponentially larger scale. Reported Earnings • May 16
Third quarter 2021 earnings released: US$0.11 loss per share (vs US$0.055 loss in 3Q 2020) Third quarter 2021 results: Net loss: US$2.32m (loss widened 165% from 3Q 2020). Recent Insider Transactions • Apr 30
Insider recently sold US$84k worth of stock On the 28th of April, M. Tompkins sold around 28k shares on-market at roughly US$2.95 per share. In the last 3 months, they made an even bigger sale worth US$364k. Insiders have been net sellers, collectively disposing of US$1.4m more than they bought in the last 12 months. Recent Insider Transactions • Apr 03
Insider recently sold US$364k worth of stock On the 1st of April, M. Tompkins sold around 87k shares on-market at roughly US$4.21 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$477k more than they bought in the last 12 months. Recent Insider Transactions • Mar 08
Insider recently sold US$112k worth of stock On the 5th of March, M. Tompkins sold around 20k shares on-market at roughly US$5.62 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Duyuru • Mar 04
Amesite Inc. Announces It Will Focus on Whole Enterprise Solutions After Successful Implementation of Its SaaS Ed-Tech Platform for The Henry Ford Museum of American Innovation Amesite Inc. announced the successful implementation of its whole enterprise solution for The Henry Ford Museum of American Innovation. Amesite's cloud-based platform and content creation services provide fully managed, customized, learning environments for business, universities, and K-12 schools. The platform has the capacity to upload an organization's entire training and educational materials into a single point of access. Amesite has been rapidly ramping up its capabilities to deliver whole-organization solutions for companies with large-scale educational, training and upskilling needs. It recently launched a complete online learning platform, inHub, for The Henry Ford Museum, an internationally recognized museum with more than 26 million primary and secondary source artifacts and lesson plans that detail more than 300 years of American innovation, ingenuity, and resourcefulness. Reported Earnings • Feb 14
Second quarter 2021 earnings released Second quarter 2021 results: Net loss: US$2.29m (loss widened 138% from 2Q 2020). Duyuru • Feb 05
Amesite Inc. Appoints Matthew Kern as Chief Financial Officer, Effective February 22, 2021 Effective February 22, 2021, the board of directors of Amesite Inc. appointed Matthew Kern as Chief Financial Officer of the Company. Prior to joining the Company, from April 2012 to February 2021, Mr. Kern was associated with Blackbaud, where he was most recently the Director of Financial Planning and Analysis. Is New 90 Day High Low • Feb 04
New 90-day high: US$5.49 The company is up 34% from its price of US$4.10 on 05 November 2020. The American market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is up 15% over the same period. Duyuru • Feb 02
Amesite Inc. Announces Advanced A.I. Driven Electric Vehicle Courses for Wayne State University Amesite Inc. announced an expansion of its partnership with Wayne State University. Created and delivered by Amesite, and targeting its alumni and members of the WSU community, the university will now offer six-week on-line, A.I. powered certification courses covering the following content: Autonomous Vehicle Technologies; Data Science; Electric Vehicle Technologies; Mobility as a Service; and programming for Autonomous Systems. The new courses will launch on February 22, 2021. Duyuru • Jan 20
Amesite Inc. Appoints Brock Bilger as Director of K-12 Sales AmesiteInc. announced that Brock Bilger has joined as Director of K-12 Sales. Bilger brings to the company 7 years of K-12 software sales expertise, most recently at Frontline Education. Duyuru • Nov 26
Amesite Inc. Announces Appointment of George Parmer to Its Board of Directors AmesiteInc. announced that global investor, developer and entrepreneur George Parmer has joined its Board of Directors. The appointment brings the total number of board members to seven. Parmer sits on the board of Linkbancorp Inc., is the Chairman of the Board of Trustees at Messiah University in Pennsylvania. He is the founder and president of residential home building and development company Fine Line Homes, which has developments along the east coast from New York to North Carolina. He is also the founder and president of nationwide company Residential Warranty Corporation and three insurance companies located in Colorado, Pennsylvania, and Texas. Duyuru • Nov 20
Amesite Inc. Announces Successful Completion of Pilot Learning Program with Ford Motor Company Amesite Inc. and K-12 announced it has successfully completed delivery of a pilot learning program for the Ford Motor Company, building content and offering the experience on its advanced platform. Amesite creates outstanding learning experiences, delivered on its advanced platform, providing a positive impact for employees. Using AI to provide fresh content creates important context for learning. Coupled with outstanding services, these experiences deepen professionals' interest in subjects important to their company's goals, and spur creative ways in which to execute on new practices. Duyuru • Oct 01
Amesite Partners with Enriched Business Strategies LLC to Bring Leadership Development Practice to the Virtual Space Amesite Inc. announced that it was partnering with Enriched Business Strategies LLC to bring EBS's leadership development practice to an online platform. Enriched Business Strategies' partnership with Amesite will formally launch later this year with an enhanced version of the leadership development curriculum EBS had been providing in person before the pandemic struck. 